Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin-converting enzyme?

Abstract

Get full access to this article

View all access options for this article.

References

Campbell

. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79: 1–6.

Campbell

Kladis

Skinner

. Characterization of angiotensin peptides in plasma of anephric man. J Hypertens 1991; 9: 265–274.

Campbell

. Critical review of prorenin and (pro)renin receptor research. Hypertension 2008; 51: 1259–1264.

Danser

AHJ

Van Kats

Admiraal

PJJ

. Cardiac renin and angiotensins: Uptake from plasma versus in situ synthesis. Hypertension 1994; 24: 37–48.

Campbell

Kladis

Duncan

A-M

. Nephrectomy, converting enzyme inhibition and angiotensin peptides. Hypertension 1993; 22: 513–522.

Moreno

Hoffman

Stodola

. Creation and characterization of a renin knockout rat. Hypertension 2011; 57: 614–619.

Yanai

Saito

Kakinuma

. Renin-dependent cardiovascular functions and renin-independent blood- brain barrier functions revealed by renin-deficient mice. J Biol Chem 2000; 275: 5–8.

Gribouval

Moriniere

Pawtowski

. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat 2012; 33: 316–326.

Nussberger

Delabays

de Gasparo

. Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers. Hypertension 1989; 13: 948–953.

10.

Nussberger

Wuerzner

Jensen

. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Hypertension 2002; 39: e1–e8.

11.

Alexiou

Boon

Denton

. Angiotensinogen and angiotensin converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice. J Hypertens 2005; 23: 945–954.

12.

Campbell

Alexiou

Xiao

. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 2004; 43: 854–859.

13.

Campbell

Kladis

Duncan

A-M

. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994; 23: 439–449.

14.

Campbell

Duncan

A-M

Kladis

. Angiotensin converting enzyme inhibition modifies angiotensin, but not kinin peptide levels in human atrial tissue. Hypertension 1999; 34: 171–175.

15.

Zeitz

Campbell

Horowitz

. Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans. Hypertension 2003; 41: 482–487.

16.

Chandrasekharan

Sanker

Glynias

. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996; 271: 502–505.

17.

Liu

Michalicek

. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. J Clin Invest 2004; 114: 112–120.

18.

Kunori

Muroga

Iidaka

. Species differences in angiotensin II generation and degradation by mast cell chymases. J Recept Signal Transduct Res 2005; 25: 35–44.

19.

Urata

Kinoshita

Misono

. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990; 265: 22348–22357.

20.

Campbell

Xiao

Fuchs

. Genetic models provide unique insight into angiotensin and bradykinin peptides in the extravascular compartment of the heart in vivo. Clin Exp Pharmacol Physiol 2009; 36: 547–553.

21.

Pitt

Poole-Wilson

Segal

. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355: 1582–1587.

22.

Takai

Jin

Miyazaki

. Multiple mechanisms for the action of chymase inhibitors. J Pharmacol Sci 2012; 118: 311–316.

23.

Uehara

Urata

Ideishi

. Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. Cardiovasc Res 2002; 55: 870–876.

24.

Dell’Italia

Meng

Balcells

. Compartmentalization of angiotensin II generation in the dog heart - Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 1997; 100: 253–258.

25.

Wei

Hase

Inoue

. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. J Clin Invest 2010; 120: 1229–1239.

26.

Kokkonen

Saarinen

Kovanen

. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid - Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity. Circulation 1997; 95: 1455–1463.